Ionis Pharmaceuticals
IONS
353 hedge funds and large institutions have $6.3B invested in Ionis Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 132 increasing their positions, 107 reducing their positions, and 52 closing their positions.
53% more call options, than puts
Call options by funds: $38M | Put options by funds: $24.8M
23% more repeat investments, than reductions
Existing positions increased: 132 | Existing positions reduced: 107
1.74% more ownership
Funds ownership: 98.16% → 99.9% (+1.7%)
0% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 52
1% less funds holding
Funds holding: 356 → 353 (-3)
8% less capital invested
Capital invested by funds: $6.83B → $6.3B (-$525M)
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$259M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$101M |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$81.3M |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$71.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$80.7M |
| 2 |
Pictet Asset Management
Carouge,
Switzerland
|
-$51.5M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$51.3M |
| 4 |
ClearBridge Investments
New York
|
-$21.3M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$18M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IC
401
Innealta Capital
Austin,
Texas
| – | -$2.24K | -47 | Closed |
|
402
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
| – | -$2.19K | -46 | Closed |
|
|
GLR
403
Great Lakes Retirement
Sandusky,
Ohio
| – | -$2.05K | -43 | Closed |
|
|
KFS
404
Kelly Financial Services
Braintree,
Massachusetts
| – | -$1.43K | -30 | Closed |
|
|
CFGS
405
Concourse Financial Group Securities
Birmingham,
Alabama
| – | -$1.21K | -26 | Closed |
|
IONS Hedge Fund Activity: Q3 2024 in Review
353 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ionis Pharmaceuticals (IONS) for Q3 2024, worth a combined $6.3B — down 7.7% from $6.83B a quarter earlier.
Fund positioning in IONS was balanced in Q3 2024: 52 funds opened new positions, 52 closed out, 132 added to existing stakes and 107 trimmed.
The largest buyer was Capital World Investors, adding an estimated $259M. The largest seller was BVF Inc, cutting an estimated $80.7M.
- 353 institutional investors held Ionis Pharmaceuticals (IONS) as of Q3 2024, down from 356 in Q2 2024.
- Funds reported $6.3B of Ionis Pharmaceuticals stock for Q3 2024, down 7.7% quarter-over-quarter.
- 52 funds opened new Ionis Pharmaceuticals positions in Q3 2024 and 52 closed out, a net change of 0 holders.
- The largest Ionis Pharmaceuticals buyer in Q3 2024 was Capital World Investors, an estimated $259M added.
- The largest Ionis Pharmaceuticals seller in Q3 2024 was BVF Inc, an estimated $80.7M sold.
Based on aggregated 13F filings for Q3 2024.